Share Name Share Symbol Market Type Share ISIN Share Description
Silence Ther. LSE:SLN London Ordinary Share GB00B9GTXM62 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -7.75p -3.80% 196.25p 196.00p 201.75p 201.75p 187.00p 197.25p 87,607 16:35:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.8 -10.4 -12.1 - 137.36

Silence Therapeutics Share Discussion Threads

Showing 50276 to 50300 of 50300 messages
Chat Pages: 2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  Older
DateSubjectAuthorDiscuss
21/11/2017
15:01
Try buying any shares via self trade , keeps sending order to dealer . Only allows purchase of 100 shares ........
partner
21/11/2017
06:37
Sure but shares are consolidating around the 200p level and plenty of news flow to come over the next 12 months. Plus free option big pharma takes us out
rogen83
20/11/2017
12:06
I thought the RNS was fairly good at pointing out that ALNYLAM are dragging their heels somewhat? SLN have defended the counter claim quick smart whilst ALNY & co haven't put out their defence of the original action taken by SLN. Market obviously doesn't agree yet?
ukeagle2aus
14/11/2017
19:06
95 pages of presentation from the capital markets day have made it to the website. Looks to be heavy on science and light on patents/litigation news, which I presume was the intent - try to reposition the company a bit in the mind of investors after all the news on strategic stakes and potential patent infringement. hTtp://www.silence-therapeutics.com/media/1721/silence-cmd-14-november-2017_download.pdf
1gw
14/11/2017
09:21
Which is why companies normally release the "material" news in a 7am rns ahead of the event - the same as they do with things like AGM statements. To be clear, I was hoping that there would be some material news released at 7am and then the event would go into the less material detail around that news.
1gw
14/11/2017
09:15
Material news is never stated as such events because it would breach stock exchange rules to disclose such information to attendees at the event in advance of the market generally.
callumross
14/11/2017
09:05
Yes I agree it's a bit disappointing not to have had news of a major development in one of the drug programmes or news on developments with Arrowhead or Alnylam. But I suppose the agenda is really about expanding investor interest in the company and so follows on from the US presentation earlier this year. Hopefully some of the "media" attendees will write up the event and put a positive spin on the potential of the company. And some of the investors will come back from the event wanting to increase their stake or take a new stake. Silence seem to have done a very good job so far this year in promoting the potential of the company and hopefully they can continue at this afternoon's event.
1gw
14/11/2017
08:25
No material new information will be provided during the presentations. That's a little disappointing given they the CEOs comments in previous news communications? Still, it depends on the type of questions from the floor I suppose? Be nice to get a nice confident confirmation that we expect to get a favourable high court decision (hope the Q is asked). GLA
ukeagle2aus
09/11/2017
10:08
No sign yet of a run-up in anticipation of the capital markets day. Have to hope for a "buy on the news" reaction now.
1gw
03/11/2017
20:26
The fact they are fighting it tells you there is something worth fighting for...ie multi millions of royalties and license fees
rogen83
03/11/2017
09:41
As if ALNY was just going to respond to the action by saying "awfully sorry we have infringed - how much do you want"!
callumross
03/11/2017
09:16
Can't decide if it was an odd reaction to the rns or not this morning. Bad news I suppose, the confirmation that Alny is counter-suing, but hardly a surprise. I was also thinking of adding if it fell to around 190p but looks like I was being a bit greedy.
1gw
03/11/2017
08:51
Bit scary this share. Lol
volsung
03/11/2017
08:50
Seems like an expedient time to add to the SIPP holding
volsung
30/10/2017
23:59
1gw hope you are right, it's simmering right now and the resistance to bounce a little after the previous sessions falls was nice to see. Wonder if there'll be a bit more news between now and the CMD?
ukeagle2aus
30/10/2017
15:35
Looks like a bit of interest today. Arrowhead bounced back at the end of last week after a brief biotech selloff I think. Only 2 weeks to go to the capital markets day. What price a decent rise ahead of that?
1gw
20/10/2017
15:12
Never any harm in taking a profit 1gw - I sold half mine at £1.70 - how daft was that in retrospect but felt the holding was becoming too large a share of my portfolio. SLN has now doubled over the year and trebled from its lows. Hoping for something similar with IRON - like SLN one of my largest holdings and like SLN been one of the dogs in my portfolio for a number of years. Hoping for a similar turnaround from dud to star!
callumross
20/10/2017
14:58
And sold a few more just now. A bit less than 1/4 of my holding gone today.
1gw
20/10/2017
08:13
I've joined the profit-taking and sold some this morning. I think the prospects are good leading up to the capital markets day, but it was getting a bit uncomfortable watching the volatility given it had become such a big weight in my portfolio. Even after this morning's sale it is still marginally the biggest holding I have, but now very close in size to a couple of other holdings.
1gw
18/10/2017
12:17
Ah, the predictable profit taking on the news. Pity the poor sod who only got 202.9p for his 1500 shares when the price dropped before the order book was rebuilt. Always the danger with setting an automatic stop loss.
callumross
18/10/2017
06:15
Align Research‏ @AlignResearch 3s3 seconds ago More Continued good news for Silence Therapeutics shareholders - https://www.investegate.co.uk/silence-therapeutics--sln-/rns/further-us-patents-granted/201710180700038740T/ … Only ncreases pressure on Alnylam to do a deal. #SLN
richie666
17/10/2017
02:21
Yes thanks from me as well 1gw. I thought he came across like the cat that knew he had a fridge full of cream. I also felt like he would prefer it if Silence remained independent and became a bigger/leading player in its own right? He certainly teed up the capital markets day with plenty of teasing and his assessment of the new chair couldn't have been scripted better to instill a lot of confidence amongst the viewing audience. Interesting month ahead, little leap in the price yesterday, but I wouldn't be surprised to see a bit of profit taking ahead of more steady ticks up over the next couple of weeks? GLA
ukeagle2aus
16/10/2017
18:21
Thanks for the link 1gw. Very interesting. Holding tight to my remaining shares having regrettably sold half at the £1.70 level.
callumross
16/10/2017
17:34
Ali doing a 12-minute slot on Proactive Investors. Thanks to jupiternmars on the LSE board for finding the link. In this interview he is starting to tease the contents of the capital markets day. He also talks at some length about the patents and covers the new chair's background (including reference to the counterbids for Dimension). He holds out the hope of more releases on the science and the medicines and fewer on the patents in the year to come. hTtps://www.youtube.com/watch?v=pQJi-PwC_t4
1gw
16/10/2017
15:15
Or perhaps she is being lined up for an executive role after the Dimension sale goes through?
1gw
Chat Pages: 2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20171121 19:39:57